BRIEF-TSO3 responds to U.S. FDA on extended claims, gives operations update

Wed Jun 1, 2016 5:25pm EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

June 2 (Reuters) - Tso3 Inc

* TSO3 responds to u.s. Regulators on extended claims and provides operations update

* Responded to a previously announced request for additional information by U.S. Food and Drug Administration

* Co's response allows FDA to continue their review for market clearance on extended claims for sterizone VP4 sterilizer in U.S.

* Production and operational improvements co made on assembly facility had a minimal impact on Q2 2016 production

* Substantially completed its improvements to its manufacturing facility in Québec

* Operational improvements to its assembly facility are designed to increase assembly capacity and efficiency Source text for Eikon: Further company coverage: